New HPV vaccine could be even more effective at protecting against cervical cancer

A new vaccine against human papillomavirus (HPV), which can cause cervical cancer, could be even more effective, according to research published in the journal Cancer Epidemology, Biomarkers, and Prevention.
The new vaccine, developed by drug maker Merck, will protect against nine strains of HPV and could be 90 percent effective. The current vaccine, GARDASIL, protects against four strains and is 70 percent effective.
Vaccination against these additional five types of HPV could be good news for women worldwide, as certain strains of HPV are more common outside of the United States and Europe — HPV 52 and 58, for example, are more common in Asia.
The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
The new vaccine is being reviewed by the FDA, and if it is approved, it could be available sometime in 2015, Time reports.
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
-
Trump proposes ending quarterly earnings reports
Speed Read The SEC would have to approve any changes
-
White House joins GOP speech policing, citing Kirk
Speed Read Yesterday’s developments ‘underscore the extraordinary amount of time and resources’ the White House has dedicated to advancing Kirk’s legacy
-
3 killed in Trump’s second Venezuelan boat strike
Speed Read Legal experts said Trump had no authority to order extrajudicial executions of noncombatants
-
Texas declares end to measles outbreak
Speed Read The vaccine-preventable disease is still spreading in neighboring states, Mexico and Canada
-
RFK Jr. shuts down mRNA vaccine funding at agency
Speed Read The decision canceled or modified 22 projects, primarily for work on vaccines and therapeutics for respiratory viruses
-
Measles cases surge to 33-year high
Speed Read The infection was declared eliminated from the US in 2000 but has seen a resurgence amid vaccine hesitancy
-
Kennedy's vaccine panel signals skepticism, change
Speed Read RFK Jr.'s new vaccine advisory board intends to make changes to the decades-old US immunization system
-
Kennedy ousts entire CDC vaccine advisory panel
speed read Health Secretary RFK Jr. is a longtime anti-vaccine activist who has criticized the panel of experts
-
RFK Jr. scraps Covid shots for pregnant women, kids
Speed Read The Health Secretary announced a policy change without informing CDC officials
-
New FDA chiefs limit Covid-19 shots to elderly, sick
speed read The FDA set stricter approval standards for booster shots
-
US overdose deaths plunged 27% last year
speed read Drug overdose still 'remains the leading cause of death for Americans aged 18-44,' said the CDC